large b-cell lymphoma: zuma-1 trial
Published 6 years ago • 89 plays • Length 5:50Download video MP4
Download video MP3
Similar videos
-
0:46
key takeaway from 2-year follow-up data of zuma-1 trial in large b-cell lymphoma
-
3:55
zuma-12: axicabtagene ciloleucel for high-risk large b cell lymphoma
-
3:41
interim results from the zuma-1 trial of novel car-t cells against non-hodgkin lymphoma
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
4:52
long term follow up on the zuma-1 trial for nhl
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
2:39
axi-cel improves survival in early r/r large b-cell lymphoma
-
0:53
design of the zuma-1 trial in non-hodgkin lymphoma
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
2:03
long-term follow-up results from the zuma-1 trial in non-hodgkin lymphoma
-
3:16
zuma-12: a phase 2 study of axi-cel as first-line therapy in patients with high-risk large b-cel...
-
5:55
results from scholar-1 trial for dlbcl patients
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
3:10
axicabtagene ciloleucel in patients with refractory large b cell lymphoma
-
2:48
zuma-1: safety and efficacy of axicabtagene in refractory non-hodgkin lymphoma patients
-
2:02
dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma
-
3:04
pet-directed therapy for early-stage diffuse large b-cell lymphoma
-
2:32
zuma-1 update: durable survival in r/r dlbcl patients treated with axi-cel